CPRX
Price
$21.46
Change
+$0.01 (+0.05%)
Updated
Jul 3 closing price
Capitalization
2.62B
30 days until earnings call
TGTX
Price
$36.72
Change
+$0.43 (+1.18%)
Updated
Jul 3 closing price
Capitalization
5.83B
29 days until earnings call
Interact to see
Advertisement

CPRX vs TGTX

Header iconCPRX vs TGTX Comparison
Open Charts CPRX vs TGTXBanner chart's image
Catalyst Pharmaceuticals
Price$21.46
Change+$0.01 (+0.05%)
Volume$687.43K
Capitalization2.62B
TG Therapeutics
Price$36.72
Change+$0.43 (+1.18%)
Volume$681.32K
Capitalization5.83B
CPRX vs TGTX Comparison Chart in %
Loading...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPRX vs. TGTX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Hold and TGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CPRX: $21.46 vs. TGTX: $36.72)
Brand notoriety: CPRX and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 56% vs. TGTX: 30%
Market capitalization -- CPRX: $2.62B vs. TGTX: $5.83B
CPRX [@Biotechnology] is valued at $2.62B. TGTX’s [@Biotechnology] market capitalization is $5.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 2 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • CPRX’s FA Score: 2 green, 3 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than CPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 5 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • CPRX’s TA Score: 5 bullish, 5 bearish.
  • TGTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than TGTX.

Price Growth

CPRX (@Biotechnology) experienced а -1.96% price change this week, while TGTX (@Biotechnology) price change was -3.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CPRX is expected to report earnings on Aug 06, 2025.

TGTX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.83B) has a higher market cap than CPRX($2.62B). TGTX has higher P/E ratio than CPRX: TGTX (146.88) vs CPRX (13.67). TGTX YTD gains are higher at: 21.993 vs. CPRX (2.827). CPRX has higher annual earnings (EBITDA): 269M vs. TGTX (70.5M). CPRX has more cash in the bank: 581M vs. TGTX (132M). CPRX has less debt than TGTX: CPRX (3.09M) vs TGTX (8.98M). CPRX has higher revenues than TGTX: CPRX (535M) vs TGTX (386M).
CPRXTGTXCPRX / TGTX
Capitalization2.62B5.83B45%
EBITDA269M70.5M382%
Gain YTD2.82721.99313%
P/E Ratio13.67146.889%
Revenue535M386M139%
Total Cash581M132M440%
Total Debt3.09M8.98M34%
FUNDAMENTALS RATINGS
CPRX vs TGTX: Fundamental Ratings
CPRX
TGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
2270
SMR RATING
1..100
3346
PRICE GROWTH RATING
1..100
6144
P/E GROWTH RATING
1..100
957
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPRX's Valuation (57) in the Pharmaceuticals Other industry is in the same range as TGTX (89) in the Biotechnology industry. This means that CPRX’s stock grew similarly to TGTX’s over the last 12 months.

CPRX's Profit vs Risk Rating (22) in the Pharmaceuticals Other industry is somewhat better than the same rating for TGTX (70) in the Biotechnology industry. This means that CPRX’s stock grew somewhat faster than TGTX’s over the last 12 months.

CPRX's SMR Rating (33) in the Pharmaceuticals Other industry is in the same range as TGTX (46) in the Biotechnology industry. This means that CPRX’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's Price Growth Rating (44) in the Biotechnology industry is in the same range as CPRX (61) in the Pharmaceuticals Other industry. This means that TGTX’s stock grew similarly to CPRX’s over the last 12 months.

TGTX's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for CPRX (95) in the Pharmaceuticals Other industry. This means that TGTX’s stock grew significantly faster than CPRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPRXTGTX
RSI
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bearish Trend 5 days ago
70%
Bullish Trend 5 days ago
87%
MACD
ODDS (%)
Bearish Trend 5 days ago
72%
Bearish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
71%
Bearish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
64%
Bullish Trend 5 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
69%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
82%
Aroon
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITGRX42.380.35
+0.83%
Macquarie Global Growth Fund R6
JANEX147.840.98
+0.67%
Janus Henderson Enterprise D
SEMCX31.490.20
+0.64%
SEI Mid-Cap F (SIMT)
BRULX16.560.09
+0.55%
MFS Blended Research Value Equity R3
TCREX17.760.03
+0.17%
Nuveen Real Estate Sec Sel A

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with SANA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+0.05%
SANA - CPRX
45%
Loosely correlated
+9.25%
CRNX - CPRX
45%
Loosely correlated
+1.22%
LGND - CPRX
45%
Loosely correlated
+0.81%
VIR - CPRX
44%
Loosely correlated
-0.37%
ARWR - CPRX
42%
Loosely correlated
-0.65%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ROIV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+1.18%
ROIV - TGTX
36%
Loosely correlated
+0.18%
CLLS - TGTX
36%
Loosely correlated
-4.24%
CPRX - TGTX
35%
Loosely correlated
+0.05%
LGND - TGTX
35%
Loosely correlated
+0.81%
KYMR - TGTX
34%
Loosely correlated
+0.58%
More